Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Stockholders Equity of $205.41 million for fiscal year 2025.
KESTRA MEDICAL TECHNOLOGIES, LTD. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $205.41M | +198.1% |
| 2024 | -$209.38M | -78.1% |
| 2023 | -$117.58M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $287.99M | +211.7% | +75.5% |
| October 31, 2025 | $164.08M | +169.4% | -10.9% |
| July 31, 2025 | $184.16M | +185.1% | -10.3% |
| April 30, 2025 | $205.41M | +198.1% | +179.6% |
| January 31, 2025 | -$257.89M | — | -9.0% |
| October 31, 2024 | -$236.54M | — | -9.3% |
| July 31, 2024 | -$216.47M | — | -3.4% |
| April 30, 2024 | -$209.38M | — | — |
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed an increase of +198.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, KESTRA MEDICAL TECHNOLOGIES, LTD.’s stockholders equity has grown by 274.7% (from -$117.58 million to $205.41 million).
- The most recent figure is from KESTRA MEDICAL TECHNOLOGIES, LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: